INSYS Therapeutics (INSY) Decline Appers Overdone - Wells Fargo
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- US futures steady as oil retreats ahead of earnings deluge, Fed decision
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil slips but stays near six-month highs on Saudi attacks
- BofA flags further downside risk for stocks, yields and dollar
INSYS Therapeutics (INSY) Stock Declines on Reports of Doctor Fraud
May 9, 2014 4:36 PM EDTINSYS Therapeutics (Nasdaq: INSY) stock tanked on reports a doctor in Michigan has been accused of defrauding Medicare by $7 million. The doctor is accused of writing 1,283 million prescriptions for Subsys in 5 years, 20.3% of Subsys prescribed to Medicare beneficiaries nationwide during this... More



